New Survey: Digestive Side Effects Cause 41% of GLP-1 Users to Suffer in Silence, Self-Adjust, or Consider Quitting Of these users, 1 in 5 believe incorrectly that GI side effects are just the price to pay, while others are quietly adjusting their own doses or stopping these popular drugs NEW YORK [July 28, 2026] A new national survey commissioned by Oshi Health and conducted by Morning Consult revealed that 75% of GLP-1 users experience a variety of digestive side effects, and that 41% are either silently enduring their symptoms, quietly adjusting medication on their own, or at risk of stopping the medication altogether
GHRP-2 at comparable concentrations elevated cortisol
Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris
Here's what to know
Federal Trade Commission (FTC) Enforcement: Pricing, Testimonials, and Subscription Practices One recent example is the FTCs NextMed action, which illustrates how telehealth weightloss programs tied to GLP1 access can draw scrutiny based on how programs are marketed, billed, and administered
But this was just the beginning